[ad_1] The committee overseeing the implementation of the study with the active ingredient RLF-100 has given the green light to continue the corona development project. Relief Therapeutics announced Thursday. The data monitoring committee reviewed data from 102 randomly selected patients followed for at least 28 days and concluded that the …
Read More »Relief Recovers After Positive News From Study | Corporate health
